|
|
| Understanding The Key Differences Between EAPs And ISTs | Guest Column | By Christopher Ohms, Ohms Consulting | Expanded Access Programs (EAPs) and Investigator-Sponsored Trials (ISTs) are pivotal, granting access to investigational therapies. Recognizing their distinctions from traditional trials is crucial for investigational medicine and supply chains, ensuring efficient operations. |
|
|
|
|
|
|
|
| Why Jane Myles Believes DCTs Are “Completely Doable” | From The Editor | By Dan Schell, chief editor, Clinical Leader | If you want to know about how perceptions regarding DCTs are changing, talk with Jane Myles of the Decentralized Trials & Research Alliance (DTRA). As Program Director at DTRA, she is acutely aware of all the challenges and opportunities surrounding anything with the term “decentralized trial.” |
|
|
| 4 Ways To Increase Diversity In Clinical Trials | e-book | Medidata AI | Uncover diversity strategies that encompass every facet of the trial lifecycle, such as the design of a patient-centric experience, proper positioning for regulatory and operational success, and more. |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
